CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: This results in apoptosis of CD34+ progenitors in patients with TKI-sensitive and -resistant CML and translates into long-term survival with normal myelopoiesis and absence of toxic effects in BCR/ABL1-positive leukemic mice (27, 38, 44).